LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code 0142U.
Signal breakdown
8 shown · 8 total in platform
Critical
0%
High
88%
Routine
13%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Policy LCD-L38988 · Infectious Disease / Microbiology
New guidelines for molecular testing requires billing team review.
Policy LCD-L39038 · Infectious Disease / Microbiology
New guidelines for molecular syndromic panels effective April 2026.
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
Policy LCD-L39003 · Infectious Disease / Microbiology
New LCD impacts pathogen identification testing billing.
Policy LCD-L39001 · Infectious Disease / Microbiology
New LCD affects billing for infectious disease testing.
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Policy LCD-L39044 · Infectious Disease / Microbiology
New LCD affects infectious disease testing coverage.
Audit documentation
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.